Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · Real-Time Price · USD
1.700
0.00 (0.00%)
At close: Jun 26, 2026, 4:00 PM EDT
1.710
+0.010 (0.59%)
After-hours: Jun 26, 2026, 6:26 PM EDT

Company Description

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally.

The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables.

The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications.

In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software.

Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems logo
Country United States
Founded 2006
IPO Date Jul 15, 2021
Industry Medical Devices
Sector Healthcare
Employees 171
CEO Robert Spignesi

Contact Details

Address:
25 Hartwell Avenue
Lexington, Massachusetts 02421
United States
Phone 978 349 3200
Website rapidmicrobio.com

Stock Details

Ticker Symbol RPID
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
IPO Price $20.00
CIK Code 0001380106
CUSIP Number 75340L104
ISIN Number US75340L1044
Employer ID 20-8121647
SIC Code 3826

Key Executives

Name Position
Robert G. Spignesi Jr. Chief Executive Officer, President, Chief Operating Officer and Director
Sean M. Wirtjes CPA Chief Financial Officer
Michael Beaulieu C.F.A. Vice President of Investor Relations and Corporate Communications
James Xu Senior Vice President of Legal and Secretary
Katherine Atkinson Senior Vice President of Global Sales and Marketing
Julie Jarvie Senior Vice President of Human Resources

Latest SEC Filings

Date Type Title
Jun 22, 2026 144 Filing
Jun 10, 2026 144 Filing
May 29, 2026 SD Form - SD
May 28, 2026 8-K Current Report
May 19, 2026 8-K Current Report
May 19, 2026 424B5 Filing
May 19, 2026 424B5 Filing
May 15, 2026 SCHEDULE 13G/A Filing
May 15, 2026 10-Q Quarterly Report
May 13, 2026 8-K Current Report